Riskpilot← Back to searchSign inGet full accessÄlvsjö Tandvård AB
ABActiveOrg 5590898598Prästgårdsgränd 4Dental practice care activities · NACE 8623Est. 201610-19 employees
Revenue 2024
SEK 19,4M
+1% vs 2023
EBITDA margin
9.3%
+5% vs 2023
Equity ratio
45.0%
Financial strength
Net profit 2024
SEK 953K
-3% vs 2023
| Revenue | SEK 19,4M | +1% |
| EBITDA | SEK 1,8M | +5% |
| Net profit | SEK 953K | -3% |
| Total assets | SEK 15,1M | +4% |
| Equity | SEK 6,8M | +4% |
| Employees | — | — |
Legal name
Älvsjö Tandvård AB
Org number
5590898598
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
9 december 2016
Share capital
SEK 50 000
Employees
10-19
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva tandvård och idka därmed förenlig verksamhet. Bolaget ska även bedriva öppenvårdsinsatser för barn och ungdomar.
Address
Prästgårdsgränd 4
Phone
+46812854555
Email
info@alvsjotandvard.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 17 212 | 18 639 | 21 278 | 19 342 | 19 447 |
| Staff expenses | — | — | −9 562 | — | — |
| EBITDA | 4 191 | 3 328 | 4 039 | 1 723 | 1 815 |
| Depreciation & amort. | −518 | −589 | −302 | −208 | −229 |
| EBIT | 3 673 | 2 739 | 3 737 | 1 515 | 1 586 |
| Net financials | −345 | 10 | −93 | 183 | 113 |
| Profit before tax | 2 507 | 2 064 | 2 733 | 1 268 | 1 244 |
| Tax | −577 | −422 | −586 | −285 | −291 |
| Net profit | 1 930 | 1 642 | 2 146 | 983 | 953 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 955 | 10 727 | 13 454 | 14 481 | 15 105 |
| Equity | 2 868 | 4 510 | 6 056 | 6 539 | 6 792 |
| Long-term debt | 652 | 637 | 430 | 486 | 681 |
| Short-term debt | 3 267 | 3 726 | 4 204 | 4 261 | 3 982 |
| Total debt | 3 919 | 4 363 | 4 634 | 4 747 | 4 663 |
EBITDA margin
9.3%
This company
15.8%
Market median
-41% vs market
20202024
Equity ratio
45.0%
This company
38.2%
Market median
+18% vs market
20202024
Return on equity
14.0%
This company
18.4%
Market median
+24% vs market
20202024
Net profit margin
4.9%
This company
8.1%
Market median
-40% vs market
20202024
Asset turnover
1.29×
This company
1.12×
Market median
+15% vs market
20202024
Debt / equity
1.22×
This company
0.62×
Market median
-97% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AZ Chief Executive Officer | Chief Executive Officer | 2022 |
EG Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Älvsjö Tandvård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Adel Zaoujan | Chief Executive Officer | 0 companies |
| Erik Gunnar Ågerup | Audit | 0 companies |
| Sofia Marjaana Hietala Yebari | Deputy Board Member | 0 companies |
| Eman Zaoujan | Deputy Board Member | 0 companies |